Omnicell (OMCL) revenue breakdown
By segment, Automation and Analytics is the largest at 83% of fiscal 2018 revenue; Medication Adherence grew fastest, 15% a year over 2 years.
By product, Connected devices, software licenses, and other is the largest at 48% of fiscal 2025 revenue; SaaS and Expert Services grew fastest, 33% a year over 7 years.
Revenue by segment
Fiscal years, as Omnicell reports them in its 10-K filings; fiscal 2018 total $787M.
| Segments | 2016 | 2017 | 2018 | Share |
|---|---|---|---|---|
| Automation and Analytics | $597M | $587M | $656M | 83% |
| Medication Adherence | $99M | $126M | $132M | 17% |
Revenue by product
Fiscal years, as Omnicell reports them in its 10-K filings; fiscal 2025 total $1.2B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Connected devices, software licenses, and other | — | — | $483M | $574M | $560M | $739M | $828M | $624M | $539M | $565M | 48% |
| Technical services | — | — | $183M | $194M | $202M | $207M | $207M | $226M | $238M | $260M | 22% |
| SaaS and Expert Services | — | — | $35M | $43M | $54M | $113M | $186M | $213M | $244M | $259M | 22% |
| Consumables | — | — | $86M | $86M | $76M | $73M | $75M | $85M | $91M | $100M | 8% |
| Product | $528M | $510M | — | — | — | — | — | — | — | — | — |
| Service | $168M | $203M | — | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Omnicell reports them in its 10-K filings; fiscal 2025 total $1.2B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $595M | $614M | $686M | $807M | $798M | $1.0B | $1.2B | $1.0B | $1.0B | $1.1B | 90% |
| Rest of world | $101M | $99M | $101M | $90M | $95M | $111M | $128M | $136M | $100M | $120M | 10% |
Questions
Where does Omnicell make its money?
In fiscal 2018, by segment: Automation and Analytics $656M, Medication Adherence $132M.
From Omnicell's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.